COMMUNIQUÉS West-GlobeNewswire
-
La Croix-Rouge canadienne met sur pied un fonds de secours pour aider les personnes touchées par les inondations au Manitoba
11/07/2026 -
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/07/2026 -
GuideAI Health Announces Marketing and Communications Programs
10/07/2026 -
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10/07/2026 -
SoliVana Wellness Lab Celebrates 3 years in Redwood City as the Bay Area's First Dedicated Nervous System Recovery Center
10/07/2026 -
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
10/07/2026 -
VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister
10/07/2026 -
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
10/07/2026 -
Canadian Red Cross opens appeal to support people impacted by flooding in Manitoba
11/07/2026 -
Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10/07/2026 -
Raw Garden Launches Solventless Live Rosin Joints
10/07/2026 -
Sanofi: Information concerning the total number of voting rights and shares - June 2026
10/07/2026 -
Sanofi: Informations relatives au nombre de droits de vote et d'actions - Juin 2026
10/07/2026 -
AB Science fait le point sur son programme clinique avec l’arrêt de certaines études cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques
10/07/2026 -
Elevar Therapeutics Receives FDA Complete Response Letter for Combination of Rivoceranib and Camrelizumab as a First-line Treatment for Unresectable or Metastatic Hepatocellular Carcinoma
10/07/2026 -
Cosmos Health Launches Subscription Model
10/07/2026 -
AB Science provides an update on its clinical program, suspending some non-priority clinical trials to focus on two clinical programs
10/07/2026 -
FDA Proposes Rule to Modernize Drug Manufacturing Registration
10/07/2026 -
SRX Global Management Team to Host Virtual Fireside Chat on July 14, 2026, and Issues Letter to Shareholders
10/07/2026
Pages